Literature DB >> 12709065

Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.

Zoltán Kukor1, Miklós Tóth, Miklós Sahin-Tóth.   

Abstract

Human pancreatic secretions contain two major trypsinogen isoforms, cationic and anionic trypsinogen, normally at a ratio of 2 : 1. Pancreatitis, pancreatic cancer and chronic alcoholism lead to a characteristic reversal of the isoform ratio, and anionic trypsinogen becomes the predominant zymogen secreted. To understand the biochemical consequences of these alterations, we recombinantly expressed and purified both human trypsinogens and documented characteristics of autoactivation, autocatalytic degradation and Ca2+-dependence. Even though the two trypsinogens are approximately 90% identical in their primary structure, we found that human anionic trypsinogen and trypsin exhibited a significantly increased (10-20-fold) propensity for autocatalytic degradation, relative to cationic trypsinogen and trypsin. Furthermore, in contrast to the characteristic stimulation of the cationic proenzyme, acidic pH inhibited autoactivation of anionic trypsinogen. In mixtures of cationic and anionic trypsinogen, an increase in the proportion of the anionic proenzyme had no significant effect on the levels of trypsin generated by autoactivation or by enterokinase at pH 8.0 in 1 mm Ca2+- conditions that were characteristic of the pancreatic juice. In contrast, rates of trypsinogen activation were markedly reduced with increasing ratios of anionic trypsinogen under conditions that were typical of potential sites of pathological intra-acinar trypsinogen activation. Thus, at low Ca2+ concentrations at pH 8.0, selective degradation of anionic trypsinogen and trypsin caused diminished trypsin production; while at pH 5.0, inhibition of anionic trypsinogen activation resulted in lower trypsin yields. Taken together, the observations indicate that up-regulation of anionic trypsinogen in pancreatic diseases does not affect physiological trypsinogen activation, but significantly limits trypsin generation under potential pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709065     DOI: 10.1046/j.1432-1033.2003.03581.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  43 in total

Review 1.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

2.  Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains.

Authors:  Edit Szepessy; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2006-06-05       Impact factor: 5.542

3.  Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans.

Authors:  Edit Szepessy; Miklós Sahin-Tóth
Journal:  Pancreatology       Date:  2005-12-01       Impact factor: 3.996

Review 4.  Human pancreatic digestive enzymes.

Authors:  David C Whitcomb; Mark E Lowe
Journal:  Dig Dis Sci       Date:  2007-01-05       Impact factor: 3.199

5.  Activation mechanism of recombinant Der p 3 allergen zymogen: contribution of cysteine protease Der p 1 and effect of propeptide glycosylation.

Authors:  Marie-Eve Dumez; Nathalie Teller; Frédéric Mercier; Tetsuya Tanaka; Isabel Vandenberghe; Michel Vandenbranden; Bart Devreese; André Luxen; Jean-Marie Frère; André Matagne; Alain Jacquet; Moreno Galleni; Andy Chevigné
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

Review 6.  Insights into the genetic risk factors for the development of pancreatic disease.

Authors:  Zachary Zator; David C Whitcomb
Journal:  Therap Adv Gastroenterol       Date:  2017-01-05       Impact factor: 4.409

7.  The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.

Authors:  Moh'd A Salameh; Alexei S Soares; Alexandra Hockla; Derek C Radisky; Evette S Radisky
Journal:  Biochem J       Date:  2011-11-15       Impact factor: 3.857

Review 8.  Genetic risk factors for pancreatic disorders.

Authors:  David C Whitcomb
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

9.  Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2012-10-30       Impact factor: 5.542

10.  The guinea pig pancreas secretes a single trypsinogen isoform, which is defective in autoactivation.

Authors:  Béla Ozsvári; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.